Immune Thrombocytopenia

• CLINICAL_TRIALS trial_result · 2009-08-11
  Clinical Trial Update: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) [Phase 2]

  Phase 2 REPEAT trial evaluating repeated exposure to eltrombopag in adults with immune thrombocytopenia has completed and results were poste…

• FDA approval · 2008-11-20
  FDA Approved: PROMACTA — Original Application (Novartis Pharmaceuticals Corporation)

  FDA approved PROMACTA (eltrombopag olamine) under the original NDA for treatment of adults with chronic immune thrombocytopenia who have had…

• CLINICAL_TRIALS trial_result · 2008-09-09
  Clinical Trial Update: Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [Phase 2]

  A Phase II trial of rituximab for immune thrombocytopenia has completed.

• FDA approval · 2008-08-22
  FDA Approved: NPLATE — Original Application (Amgen, Inc)

  FDA approved NPLATE (romiplostim) under the original biologics license application for the treatment of chronic immune thrombocytopenia.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Daclizumab to Treat Chronic Immune Thrombocytopenia [Phase 2]

  Phase 2 clinical trial of daclizumab for chronic immune thrombocytopenia has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

  A completed NHLBI observational trial in immune thrombocytopenia examined how platelet counts relate to endogenous thrombopoietin levels, en…

• CLINICAL_TRIALS research · 2006-05-31
  Clinical Trial Update: Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire

  A prospective cohort study in Pays de la Loire evaluating acute immune or idiopathic thrombocytopenic purpura in children; the current trial…